Exact Mass: 622.4022

(20R)-Ginsenoside Rh2

C36H62O8 (622.4444)

(20S)-ginsenoside Rh2 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite, an antineoplastic agent, an apoptosis inducer, a cardioprotective agent, a bone density conservation agent and a hepatoprotective agent. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a ginsenoside, a tetracyclic triterpenoid and a 20-hydroxy steroid. It derives from a hydride of a dammarane. Ginsenoside Rh2 is a natural product found in Panax ginseng and Panax notoginseng with data available. A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Ginsenoside K

C36H62O8 (622.4444)

Ginsenoside C-K is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite, an antineoplastic agent, a hepatoprotective agent, an anti-allergic agent and an anti-inflammatory agent. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a ginsenoside, a tetracyclic triterpenoid, a 3beta-hydroxy steroid and a 3beta-hydroxy-4,4-dimethylsteroid. It derives from a hydride of a dammarane. ginsenoside C-K is a natural product found in Panax ginseng and Fusarium sacchari with data available. A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively. Ginsenoside K. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=39262-14-1 (retrieved 2024-10-17) (CAS RN: 39262-14-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

NAc-FnorLRF-amide

C32H46N8O5 (622.3591)

(20R)-Ginsenoside Rh2

C36H62O8 (622.4444)

(20R)-Ginsenoside Rh2 is found in tea. (20R)-Ginsenoside Rh2 is isolated from Panax ginseng (ginseng). Isolated from Panax ginseng (ginseng). Ginsenoside Rh2 is found in tea. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Squamosinin A

C36H62O8 (622.4444)

Squamosinin A is found in fruits. Squamosinin A is a constituent of Annona squamosa (sugar apple). Constituent of Annona squamosa (sugar apple). Squamosinin A is found in fruits.

Bafilomycin A1(Baf-A1)

C35H58O9 (622.4081)

Ginsenoside C-K

C36H62O8 (622.4444)

Pterocaryoside B

C35H58O9 (622.4081)

PA(10:0/18:1(12Z)-2OH(9,10))

C31H59O10P (622.3846)

PA(10:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/10:0)

C31H59O10P (622.3846)

PA(18:1(12Z)-2OH(9,10)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/10:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

DG(13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/13:0/0:0)

C36H62O8 (622.4444)

DG(PGE2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/13:0)

C36H62O8 (622.4444)

DG(PGE2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/13:0/0:0)

C36H62O8 (622.4444)

DG(PGD2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/13:0)

C36H62O8 (622.4444)

DG(PGD2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(a-13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(PGE2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(PGE2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(a-13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(PGD2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(PGD2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(i-13:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(PGE2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(PGE2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(i-13:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(PGD2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(PGD2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Ginsenoside Rh10

C36H62O8 (622.4444)

Cilistol t

C34H54O10 (622.3717)

(+)-Trienomycin A

C36H50N2O7 (622.3618)

14,15-Irpexanoxide

C36H62O8 (622.4444)

Trienomycin G

C36H50N2O7 (622.3618)

Beesioside A

C35H58O9 (622.4081)

Notoginsenoside R7

C36H62O8 (622.4444)

SCHEMBL80087

C32H62O11 (622.4292)

Ginsenosid C-K

C36H62O8 (622.4444)

ocotillol II 3-O-caffeate

C39H58O6 (622.4233)

(22S)-cholest-5-ene-3beta,11beta,16beta,22-tetrol 16-O-(2-O-acetyl-alpha-L-rhamnopyranoside)

C35H58O9 (622.4081)

C39H58O6

C39H58O6 (622.4233)

physordinose C

C30H54O13 (622.3564)

NF00659A2

C38H54O7 (622.3869)

27-(4-hydroxy-3-methoxybenzoyloxy)-betulinic acid

C38H54O7 (622.3869)

Barringtogenol-C28-O-lyxosid

C35H58O9 (622.4081)

bafilomycin A1

C35H58O9 (622.4081)

The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors

Thiothece 484

C42H54O4 (622.4022)

16S,16-decarbomethoxytetrahydrosecamine

C40H54N4O2 (622.4247)

cyclosilversigenin 3-O-beta-D-xylopyranoside

C35H58O9 (622.4081)

C35H58O9

C35H58O9 (622.4081)

milicifoline B

C43H58O3 (622.4386)

Astramembrannin II

C35H58O9 (622.4081)

3beta,20(S),24(S)-trihydroxydammar-25-ene 3-O-caffeate

C39H58O6 (622.4233)

gagunin D

C34H54O10 (622.3717)

cyclosiversigenin 3-O-beta-D-xylopyranoside|trigonoside I

C35H58O9 (622.4081)

C34H54O10

C34H54O10 (622.3717)

(24S)-24-ethyl-cholesta-7,22E-diene-5alpha,6beta,25-triol 3-O-beta-D-glucoside|recurvoside A

C35H58O9 (622.4081)

7beta-(4-hydroxy-3-methoxybenzoyloxy)-betulinic acid

C38H54O7 (622.3869)

gagunin F

C34H54O10 (622.3717)

C36H62O8

C36H62O8 (622.4444)

C31H58O12

C31H58O12 (622.3928)

biselyngbyaside B

C34H54O10 (622.3717)

(2alpha,3beta,18beta)-23-O-(trans-caffeoyl)-19(18?17)-abeo-28-norolean-12-ene-2,3,18-triol|leonurusoleanolide I

C38H54O7 (622.3869)

(20SR,24RS)-epoxy-9,19-cyclolanostane-3beta,12beta,16beta,25-tetraol-3-O-beta-D-xylopyranoside

C35H58O9 (622.4081)

21beta,24-dihydroxyserrat-14-en-3alpha-yl dihydrocaffeate|lycophlegmarinol A

C39H58O6 (622.4233)

(2alpha,3beta,18beta)-3-O-(trans-caffeoyl)-19(18?17)-abeo-28-norolean-12-ene-2,18,23-triol|leonurusoleanolide J

C38H54O7 (622.3869)

3-O-beta-D-xylopyranosyl-3,6,16,25-tetrahydroxy-20(R),25(S)-epoxycycloartane|hareftoside C

C35H58O9 (622.4081)

Sipholenoside B

C36H62O8 (622.4444)

6alpha,16alpha,20beta,21alpha-tetrahydroxytetrahymanol

C36H62O8 (622.4444)

pterocaryoside B

C35H58O9 (622.4081)

1-methoxy-6,8-dimethyl-beta-naphthyl-beta-L-arabinopyranosyl-4-pimaran-17-oic acid ester|catharanthusopimaranoside B

C38H54O7 (622.3869)

Filipin I

C35H58O9 (622.4081)

4,6,8,12,14,16-hexahydroxy-3-ethyl-15-carboxyl-27-methyl-28-isopropyloxacyclooctacosa-17,19,21,23,25-pentaen-2-one|strevertene F

C34H54O10 (622.3717)

3alpha,16alpha,21beta,22alpha,28-pentahydroxyolean-12-en-28-O-beta-D-xylopyranoside

C35H58O9 (622.4081)

crossasteroside P3

C35H58O9 (622.4081)

3beta,16alpha,21beta,22alpha,28-pentahydroxyolean-12-en-28-O-beta-xylopyranoside

C35H58O9 (622.4081)

3beta,20(S),25-trihydroxydammar-23(Z)-ene 3-O-caffeate

C39H58O6 (622.4233)

Cycloalpioside D

C35H58O9 (622.4081)

(22S)-cholest-5-ene-3beta,11beta,16beta,22-tetrol 16-O-(3-O-acetyl-alpha-L-rhamnopyranoside)

C35H58O9 (622.4081)

Leu Pro Arg Leu Pro

C30H54N8O6 (622.4166)

C36H50N2O7_(5R,13S,14R,15R)-15,22-Dihydroxy-5-methoxy-14,16-dimethyl-3-oxo-2-azabicyclo[18.3.1]tetracosa-1(24),6,8,10,16,20,22-heptaen-13-yl N-(cyclohexylcarbonyl)-D-alaninate

C36H50N2O7 (622.3618)

ginsenoside compound K

C36H62O8 (622.4444)

Annotation level-1

Ginsenoside Rh2 (S-FORM)

C36H62O8 (622.4444)

Annotation level-1

legonoxamine G

C30H50N6O8 (622.369)

Ginsenoside Rh2

C36H62O8 (622.4444)

20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4]. 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4]. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner. Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

Squamosinin A

C36H62O8 (622.4444)

Thiothece-484

C42H54O4 (622.4022)

1,1-(decane-1,10-diyl)bis[4-(octylamino)pyridinium] dichloride

C36H64Cl2N4 (622.4508)

Octenidine hydrochloride

C36H64Cl2N4 (622.4508)

D000890 - Anti-Infective Agents C254 - Anti-Infective Agent

zinc linoleate

C36H62O4Zn (622.3939)

20(S)-Ginsenoside Rh2

C36H62O8 (622.4444)

20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4]. 20(R)-Ginsenoside Rh2, a matrix metalloproteinase (MMP) inhibitor, acts as a cell antiproliferator. It has anticancer effects via blocking cell proliferation and causing G1 phase arrest. 20(R)-Ginsenoside Rh2 induces apoptosis, and has anti-inflammatory and antioxidative activity[1][2][3]. 20(R)-Ginsenoside Rh2 inhibits the replication and proliferation of mouse and human gammaherpesvirus 68 (MHV-68) with an IC50 of 2.77 μM for murine MHV-68[4].

P-Isopropyldihomooxacalix[4]arene

C41H50O5 (622.3658)

Bis-propargyl-PEG12

C30H54O13 (622.3564)

17-hydroxyoleic acid 17-O-sophoroside

C30H54O13 (622.3564)

Diundecyl Phosphatidyl Choline

C32H65NO8P+ (622.4448)

cyclohexane-1-carbonyl-D-alanyl-3-O-methylprotoansatrienin

C36H50N2O7 (622.3618)

DLPC;L-beta,gamma-Dilauroyl-alpha-lecithin

C32H65NO8P+ (622.4448)

(3E,5E,11E,13Z)-16-[4-(2,4-dihydroxy-5-methyl-6-propan-2-yloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

3-[3-[(E)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-(3,4,5-trihydroxyoxan-2-yl)oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C35H58O9 (622.4081)

PA(10:0/18:1(12Z)-2OH(9,10))

C31H59O10P (622.3846)

PA(18:1(12Z)-2OH(9,10)/10:0)

C31H59O10P (622.3846)

DG(13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/13:0)

C36H62O8 (622.4444)

DG(13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/13:0)

C36H62O8 (622.4444)

DG(a-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(a-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/a-13:0)

C36H62O8 (622.4444)

DG(i-13:0/PGE2/0:0)

C36H62O8 (622.4444)

DG(PGE2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGE2)

C36H62O8 (622.4444)

DG(PGE2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(i-13:0/PGD2/0:0)

C36H62O8 (622.4444)

DG(PGD2/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/PGD2)

C36H62O8 (622.4444)

DG(PGD2/0:0/i-13:0)

C36H62O8 (622.4444)

DG(13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/13:0/0:0)

C36H62O8 (622.4444)

DG(13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/13:0)

C36H62O8 (622.4444)

DG(a-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-13:0/0:0)

C36H62O8 (622.4444)

DG(a-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-13:0)

C36H62O8 (622.4444)

DG(i-13:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-13:0/0:0)

C36H62O8 (622.4444)

DG(i-13:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C36H62O8 (622.4444)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-13:0)

C36H62O8 (622.4444)

1,2-Dilauroyl-sn-glycero-3-phosphoserine(1-)

C30H57NO10P- (622.372)

A 3-sn-phosphatidyl-L-serine(1-) that is the conjugate base of 1,2-dilauroyl-sn-glycero-3-phosphoserine, obtained by deprotonation of the phosphate OH group; major species at pH 7.3.

N-[(3R,9S,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9S,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9S,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9S,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9S,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9R,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9R,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9S,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9R,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9R,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9S,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9R,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9S,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9R,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9R,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9R,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3S,9S,10S)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9R,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[(3R,9S,10R)-9-[[[cyclohexyl(oxo)methyl]-methylamino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9S,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9R,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9R,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9S,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9R,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9R,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9R,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9R,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3S,9S,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9S,10R)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

N-[[(3R,9S,10S)-16-[[cyclohexyl(oxo)methyl]amino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide

C35H50N4O6 (622.373)

O-(1-O-Hexadecanoyl-2-O-octanoyl-L-glycero-3-phospho)choline

C32H65NO8P+ (622.4448)

2-[[(2R)-2-decanoyloxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[[(2R)-2-hexanoyloxy-3-octadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[hydroxy-[(2R)-3-tridecanoyloxy-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[hydroxy-[(2R)-3-nonanoyloxy-2-pentadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[hydroxy-[(2R)-2-tridecanoyloxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

[O-[1-O-Palmitoyl-2-O-(7-oxoheptanoyl)-L-glycero-3-phospho]choline]anion

C31H61NO9P+ (622.4084)

(Z)-18-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxyoctadec-9-enoic acid

C30H54O13 (622.3564)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-hexacos-15-enoate

C32H63O9P (622.4209)

Mgdg O-22:5_4:0

C35H58O9 (622.4081)

Mgdg O-18:5_8:0

C35H58O9 (622.4081)

Mgdg O-8:0_18:5

C35H58O9 (622.4081)

Mgdg O-24:5_2:0

C35H58O9 (622.4081)

Mgdg O-20:5_6:0

C35H58O9 (622.4081)

PE-Cer 14:2;2O/18:4

C34H59N2O6P (622.4111)

PE-Cer 16:2;2O/16:4

C34H59N2O6P (622.4111)

PE-Cer 16:3;2O/16:3

C34H59N2O6P (622.4111)

PE-Cer 14:1;2O/18:5

C34H59N2O6P (622.4111)

PE-Cer 12:2;2O/20:4

C34H59N2O6P (622.4111)

PE-Cer 12:1;2O/20:5

C34H59N2O6P (622.4111)

PE-Cer 14:3;2O/18:3

C34H59N2O6P (622.4111)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] decanoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (Z)-tetradec-9-enoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-tridec-9-enoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] undecanoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-pentadec-9-enoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] dodecanoate

C32H63O9P (622.4209)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] tridecanoate

C32H63O9P (622.4209)

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C32H63O9P (622.4209)

[(4E,8E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H59N2O6P (622.4111)

[(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H59N2O6P (622.4111)

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl (6Z,9Z)-dodeca-6,9-dienoate

C39H58O6 (622.4233)

alpha-D-threo-Pentopyranose, 2,4-dideoxy-1-C-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-4-methyl-5-C-(1-methylethyl)-, (5R)-

C35H58O9 (622.4081)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C34H54O10 (622.3717)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C34H54O10 (622.3717)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C34H54O10 (622.3717)

[(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H59N2O6P (622.4111)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-docos-13-enoate

C31H59O10P (622.3846)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-nonadec-9-enoate

C31H59O10P (622.3846)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate

C31H59O10P (622.3846)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C31H59O10P (622.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-icos-11-enoate

C31H59O10P (622.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C31H59O10P (622.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C31H59O10P (622.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C31H59O10P (622.3846)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

C31H59O10P (622.3846)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-docos-13-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-icos-11-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C31H59O10P (622.3846)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C34H55O8P (622.3634)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-henicos-11-enoate

C31H59O10P (622.3846)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C34H55O8P (622.3634)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-tridec-9-enoate

C31H59O10P (622.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C31H59O10P (622.3846)

2-[[(2R)-3-decanoyloxy-2-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(3-Decanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[Hydroxy-(2-tridecanoyloxy-3-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[Hydroxy-(3-nonanoyloxy-2-pentadecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(3-Hexanoyloxy-2-octadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

[1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C34H55O8P (622.3634)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-tetradec-9-enoate

C31H59O10P (622.3846)

[1-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C34H55O8P (622.3634)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-pentadec-9-enoate

C31H59O10P (622.3846)

[1-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C34H55O8P (622.3634)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-pentadec-9-enoate

C31H59O10P (622.3846)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C31H59O10P (622.3846)

2-[(3-Acetyloxy-2-docosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(2-Hexadecanoyloxy-3-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(2-Henicosanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(3-Butanoyloxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[Hydroxy-(2-nonadecanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[(2-Heptadecanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H65NO8P+ (622.4448)

2-[carboxy-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C35H60NO8+ (622.4319)

2-[[3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H57NO7P+ (622.3872)

1,2-dilauroyl-sn-glycero-3-phosphocholine(1+)

C32H65NO8P (622.4448)

A A 1,2-diacyl-sn-glycero-3-phosphocholine(1+) that is the dilauroyl diester of phosphatidiylcholine.

FAHFA 21:7/O-21:7

C42H54O4 (622.4022)

MGDG O-25:6;O

C34H54O10 (622.3717)

MGDG O-26:5

C35H58O9 (622.4081)

MGMG 26:5

C35H58O9 (622.4081)

MGGA 25:5

C34H54O10 (622.3717)

PA O-16:0/12:2;O3

C31H59O10P (622.3846)

PA O-20:0/8:2;O3

C31H59O10P (622.3846)

PA O-20:0/9:1;O2

C32H63O9P (622.4209)

PA O-28:2;O3

C31H59O10P (622.3846)

PA O-29:1;O2

C32H63O9P (622.4209)

PA 20:0/8:1;O2

C31H59O10P (622.3846)

PA 28:1;O2

C31H59O10P (622.3846)

PA 9:0_22:6

C34H55O8P (622.3634)

LPG 26:1

C32H63O9P (622.4209)

PG O-14:1/12:0

C32H63O9P (622.4209)

PG O-16:1/10:0

C32H63O9P (622.4209)

PG O-22:0/4:1

C32H63O9P (622.4209)

PG O-22:1/4:0

C32H63O9P (622.4209)

PG O-25:2;O

C31H59O10P (622.3846)

PG O-26:1

C32H63O9P (622.4209)

PG P-14:0/12:0

C32H63O9P (622.4209)

PG P-14:0/12:0 or PG O-14:1/12:0

C32H63O9P (622.4209)

PG P-16:0/10:0

C32H63O9P (622.4209)

PG P-16:0/10:0 or PG O-16:1/10:0

C32H63O9P (622.4209)

PG P-16:0/9:1;O

C31H59O10P (622.3846)

PG P-20:0/5:1;O

C31H59O10P (622.3846)

PG P-22:0/4:0

C32H63O9P (622.4209)

PG P-22:0/4:0 or PG O-22:1/4:0

C32H63O9P (622.4209)

PG P-26:0

C32H63O9P (622.4209)

PG P-26:0 or PG O-26:1

C32H63O9P (622.4209)

PG 10:0_15:1

C31H59O10P (622.3846)

PG 11:0_14:1

C31H59O10P (622.3846)

PG 21:0/4:1

C31H59O10P (622.3846)

PG 25:1

C31H59O10P (622.3846)

LPEth 30:6

C35H59O7P (622.3998)

LPM 31:6

C35H59O7P (622.3998)

PEth 27:0;O

C32H63O9P (622.4209)

PEth 29:6

C34H55O8P (622.3634)

PM 28:0;O

C32H63O9P (622.4209)

PM 30:6

C34H55O8P (622.3634)

CerPE 14:2;O2/18:4

C34H59N2O6P (622.4111)

CerPE 32:6;O2

C34H59N2O6P (622.4111)

ST 28:2;O4;GlcA

C34H54O10 (622.3717)

ST 29:1;O3;GlcA

C35H58O9 (622.4081)

ST 28:3;O5;Hex

C34H54O10 (622.3717)

ST 29:2;O4;Hex

C35H58O9 (622.4081)

(2r,3s,4z,6z,8z,10z,12z,14r,15r,16r,18r,22s,24s,26s,27r)-27-ethyl-14,16,18,22,24,26-hexahydroxy-2-isopropyl-3-methyl-28-oxo-1-oxacyclooctacosa-4,6,8,10,12-pentaene-15-carboxylic acid

C34H54O10 (622.3717)

(4r,6s,8s,9e,11s,13e,15e,18r)-4-{[(2r,3r,4s,5s,6s)-3,5-dihydroxy-4,6-dimethoxyoxan-2-yl]oxy}-6-hydroxy-8-methoxy-9,11-dimethyl-18-[(1z,4e)-2-methylhexa-1,4-dien-1-yl]-1-oxacyclooctadeca-9,13,15-trien-2-one

C34H54O10 (622.3717)

(3s,4r,4ar,5r,6as,6br,8ar,10r,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4a-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,5,10-tetrol

C35H58O9 (622.4081)

1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-6,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-hydroxy-6-methylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O9 (622.4081)

(3z,5e,9s,11e,13e,15s)-16-{4-[(5r)-6-ethyl-2-hydroxy-4-methoxy-5-methyloxan-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(3z,5e,7r,8s,9r,11z,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(2s,3r,4s,5s,6r)-2-{[(1s,2s,4r,6s)-4-[(1s)-1-[(1r,3as,3bs,7r,9s,9ar,9bs,11as)-7,9-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H54O10 (622.3717)

2,2,6a,6b,9,9,12a-heptamethyl-4a-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,5,10-tetrol

C35H58O9 (622.4081)

n-(1-oxo-1-{[(8z,10z,16z)-3,13,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-15-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C36H50N2O7 (622.3618)

20(R)-Ginsenoside-Rh2

C36H62O8 (622.4444)

{"Ingredient_id": "HBIN003464","Ingredient_name": "20(R)-Ginsenoside-Rh2","Alias": "20(r)-ginsenoside-rh2","Ingredient_formula": "C36H62O8","Ingredient_Smile": "CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C","Ingredient_weight": "622.9 g/mol","OB_score": "6.543197059","CAS_id": "NA","SymMap_id": "SMIT11998;SMIT15578","TCMID_id": "8435","TCMSP_id": "MOL011043","TCM_ID_id": "NA","PubChem_id": "54580480","DrugBank_id": "NA"}

20(s)-ginsenosiderh2

C36H62O8 (622.4444)

{"Ingredient_id": "HBIN003507","Ingredient_name": "20(s)-ginsenosiderh2","Alias": "20(s)-ginsenoside-rh2","Ingredient_formula": "C36H62O8","Ingredient_Smile": "CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C","Ingredient_weight": "622.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15579;SMIT19217","TCMID_id": "8436;31041","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706655","DrugBank_id": "NA"}

astramembrannin ii

C35H58O9 (622.4081)

{"Ingredient_id": "HBIN017247","Ingredient_name": "astramembrannin ii","Alias": "NA","Ingredient_formula": "C35H58O9","Ingredient_Smile": "CC1(C(CCC23C1C(CC4C2(C3)CCC5(C4(CC(C5C6(CCC(O6)C(C)(C)O)C)O)C)C)O)OC7C(C(C(CO7)O)O)O)C","Ingredient_weight": "622.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14414","TCMID_id": "1946","TCMSP_id": "NA","TCM_ID_id": "6518","PubChem_id": "132492418","DrugBank_id": "NA"}

beesioside a

C35H58O9 (622.4081)

{"Ingredient_id": "HBIN017675","Ingredient_name": "beesioside a","Alias": "NA","Ingredient_formula": "C35H58O9","Ingredient_Smile": "CC1(C2CCC3C4(CC(C(C4(CCC35C2(C5)CCC1OC6C(C(C(CO6)O)O)O)CO)C7(CCC(O7)C(C)(C)O)C)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2192","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s,5s)-2,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(17z,19z,21z,23z,25z,27s,28r)-3-hexyl-6,8,10,12,14,16,27-heptahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C35H58O9 (622.4081)

1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

3a-(hydroxymethyl)-1-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a-pentamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r)-2,6,6-trimethyloxan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

3,7,11,15-tetrahydroxy-17-[3-hydroxy-2,4,6-trimethyl-6-(2-methylbutyl)oxan-2-yl]-2,4,6,10,14,16-hexamethylheptadeca-4,8,12,16-tetraenoic acid

C36H62O8 (622.4444)

2-[(8,11-dihydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(2s,3r,4r,5s,6r)-2-{[(3s,4s,7e)-1-[(2r,3r)-3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3-methyloxiran-2-yl]-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

4-[(3,5-dihydroxy-4,6-dimethoxyoxan-2-yl)oxy]-6-hydroxy-8-methoxy-9,11-dimethyl-18-(2-methylhexa-1,4-dien-1-yl)-1-oxacyclooctadeca-9,13,15-trien-2-one

C34H54O10 (622.3717)

(3r,6s,9r,12s,15r,20as)-1,13-dihydroxy-15-(1-hydroxycyclopropyl)-3,6,9,12-tetraisopropyl-8-methyl-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[2,1-l]1,7-dioxa-4,10,13,16-tetraazacyclooctadecane-4,7,10,16-tetrone

C31H50N4O9 (622.3578)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10br)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4a,4b,7,10a-hexamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-8-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H54O7 (622.3869)

2-({2-[(acetyloxy)methyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)-5-hydroxy-6-(hydroxymethyl)-4-(2-methylpropoxy)oxan-3-yl dodecanoate

C30H54O13 (622.3564)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-3',3',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H54O7 (622.3869)

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s,5e)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(2s,3s,4s,5s,6r)-2-{[(7e)-1-{3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3-methyloxiran-2-yl}-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(1s,3ar,3br,5ar,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

1-(2,5-dihydroxy-6-methylhept-6-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(1r,3bs,5s,5as,7s,9as,9br,11ar)-1-[(2r,3e,5s,6r)-7-{[(2s,3s,4r,5s,6s)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy}-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-3b,5,7-triol

C35H58O9 (622.4081)

2-({1-[3-(4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl]-4-hydroxy-4,8,12-trimethyltrideca-7,11-dien-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

3-{[5-({2-[(5-aminopentyl)(hydroxy)carbamoyl]-1-hydroxyethylidene}amino)pentyl](hydroxy)carbamoyl}-n-[5-(n-hydroxy-2-phenylacetamido)pentyl]propanimidic acid

C30H50N6O8 (622.369)

2-[(2-{7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-en-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

n-(1-oxo-1-{[(6e,8e,10z,16e)-3,15,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C36H50N2O7 (622.3618)

(3e,5z,7r,8s,9s,11z,13z,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-6-ethyl-4-hydroxy-2-methoxy-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

2-{[(1s,3ar,3br,7s,9ar,9br,11r)-11-hydroxy-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(3z,5e,11e,13e)-16-[4-(2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10br)-1,8,9-trihydroxy-4',4',4a,4b,7,10a-hexamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-7-ylmethyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H54O7 (622.3869)

methyl 2,6,10,15,19,23,23-heptamethyl-24-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]tetracosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C38H54O7 (622.3869)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,10s,11s,12s,14s,15r,16r)-10,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

n-[(2s)-1-oxo-1-{[(5r,6e,8e,10z,13s,14r,15s,16e)-3,13,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-15-yl]oxy}propan-2-yl]cyclohexanecarboximidic acid

C36H50N2O7 (622.3618)

3,8,13a-trihydroxy-2,9,9,12-tetramethyl-4-[(2-methylbutanoyl)oxy]-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-7-yl 2-methylbutanoate

C34H54O10 (622.3717)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8s,10s,11r,12s,14s,15r,16r)-10,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

2-({5-[2-(3,7-dihydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-1,4,4,6-tetramethyl-2,3,3a,5,8,8a-hexahydroazulen-1-yl}oxy)-6-methyloxane-3,4,5-triol

C36H62O8 (622.4444)

(3z,5e,7r,8s,9s,11e,13e,15s)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,11s,12s,12as,12br,14ar,14br)-11-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

1-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s,5r)-2,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

n-[1-oxo-1-({3,13,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-15-yl}oxy)propan-2-yl]cyclohexanecarboximidic acid

C36H50N2O7 (622.3618)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2s,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

4a-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,5,10-tetrol

C35H58O9 (622.4081)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-3a-(hydroxymethyl)-1-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a-pentamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

C35H58O9 (622.4081)

(2r,3r,4s,5r,6r)-2-{[(2s,3s,4s,5r)-2-[(acetyloxy)methyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-4-(2-methylpropoxy)oxan-3-yl dodecanoate

C30H54O13 (622.3564)

2-({9,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)oxane-3,4,5-triol

C35H58O9 (622.4081)

(2r,3r,4r,5s,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10s,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl acetate

C35H58O9 (622.4081)

(3e,5e,7r,8r,9s,11e,13e,15s)-16-[(2s,3r,4s)-4-[(2s,4s,5r,6s)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s,4z)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O6 (622.4233)

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8s,8as,11s,12s,12as,12br,14ar,14br)-8,11-dihydroxy-4,4,6a,6b,8a,11,12,14b-octamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

16-[4-(6-ethyl-4-hydroxy-2-methoxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(3z,5e,7r,8s,9s,11e,13e,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5r,6r)-2,4-dihydroxy-6-isopropyl-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9bs,11r,11ar)-11-hydroxy-1-[(2r)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

3-[(3s,3ar,4r,5ar,6s,7s,9ar,9br)-3-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid

C35H58O9 (622.4081)

(2s,3s,3ar,4r,6s,7s,8s,12s,13ar)-3,8,13a-trihydroxy-2,9,9,12-tetramethyl-4-{[(2r)-2-methylbutanoyl]oxy}-5-methylidene-6-[(2-methylpropanoyl)oxy]-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h,12h-cyclopenta[12]annulen-7-yl (2r)-2-methylbutanoate

C34H54O10 (622.3717)

10-hydroxy-8-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-4,4,7a,11b-tetramethyl-9-methylidene-decahydronaphtho[2,1-b]oxepin-3-yl (2e,4e,6e)-8-methyldeca-2,4,6-trienoate

C38H54O7 (622.3869)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-3',3',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H54O7 (622.3869)

2-{[11-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

16-[4-(6-ethyl-2-hydroxy-4-methoxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

2-{[1-(5-ethyl-6-hydroxy-6-methylhept-3-en-2-yl)-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O9 (622.4081)

2-({10,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)oxane-3,4,5-triol

C35H58O9 (622.4081)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8s,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

(1r,3as,3bs,4r,9ar,9bs,11ar)-1-[(2s,3r,5r)-5,6-dihydroxy-5,6-dimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C34H54O10 (622.3717)

2-({6,14-dihydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-yl}oxy)oxane-3,4,5-triol

C35H58O9 (622.4081)

(3s,4r,4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4a-({[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,5,10-tetrol

C35H58O9 (622.4081)

(3r,3as,4s,5ar,5br,7ar,11ar,11br,13ar,13br)-3,13-dihydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a,13b-hexamethyl-4-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-tetradecahydrocyclopenta[a]chrysen-9-one

C35H58O9 (622.4081)

2-{[11-hydroxy-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H62O8 (622.4444)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-3',3',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H54O7 (622.3869)

2-{[7,10-dihydroxy-1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-4-yl acetate

C35H58O9 (622.4081)

(1s,6r,9s,10r,12r,15s,18r,19s,26s,28s,31r)-6,9,12,15,18,23,31,34-octamethyl-28-(prop-1-en-2-yl)-2,25-dioxaoctacyclo[24.5.3.0¹,²⁶.0³,²⁴.0⁵,²².0⁶,¹⁹.0⁹,¹⁸.0¹⁰,¹⁵]tetratriaconta-3(24),4,20,22,33-pentaen-13-one

C43H58O3 (622.4386)

(2s,3r,4r,5r,6s)-2-{[(1r,3ar,5s,8ar)-5-{2-[(3r,5ar,6r,7s,9ar)-3,7-dihydroxy-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-1,4,4,6-tetramethyl-2,3,3a,5,8,8a-hexahydroazulen-1-yl]oxy}-6-methyloxane-3,4,5-triol

C36H62O8 (622.4444)

(4e,8e,12e,16e)-3,7,11,15-tetrahydroxy-17-[(2s,3r,4s,6r)-3-hydroxy-2,4,6-trimethyl-6-(2-methylbutyl)oxan-2-yl]-2,4,6,10,14,16-hexamethylheptadeca-4,8,12,16-tetraenoic acid

C36H62O8 (622.4444)

6,9,12,15,18,23,31,34-octamethyl-28-(prop-1-en-2-yl)-2,25-dioxaoctacyclo[24.5.3.0¹,²⁶.0³,²⁴.0⁵,²².0⁶,¹⁹.0⁹,¹⁸.0¹⁰,¹⁵]tetratriaconta-3(24),4,20,22,33-pentaen-13-one

C43H58O3 (622.4386)

(2r,3r,4r,5r,6s)-2-{[(1r,2s,3as,3bs,7s,9ar,9bs,10s,11as)-7,10-dihydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

C35H58O9 (622.4081)

1-(7-{[3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy}-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-3b,5,7-triol

C35H58O9 (622.4081)

4,5-dihydroxy-6-[(1-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-3-yl 7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C38H54O7 (622.3869)

(3r,4r,4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-4a-({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,5,10-tetrol

C35H58O9 (622.4081)

10-hydroxy-8-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-4,4,7a,11b-tetramethyl-9-methylidene-decahydronaphtho[2,1-b]oxepin-3-yl 8-methyldeca-2,4,6-trienoate

C38H54O7 (622.3869)

n-(1-oxo-1-{[(8e,10e,16z)-3,15,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C36H50N2O7 (622.3618)

3-hexyl-6,8,10,12,14,16,27-heptahydroxy-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one

C35H58O9 (622.4081)

1,13-dihydroxy-15-(1-hydroxycyclopropyl)-3,6,9,12-tetraisopropyl-8-methyl-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[2,1-l]1,7-dioxa-4,10,13,16-tetraazacyclooctadecane-4,7,10,16-tetrone

C31H50N4O9 (622.3578)

(3z,5e,7r,8s,9s,11e,13e,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-6-ethyl-4-hydroxy-2-methoxy-5-methyloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O9 (622.4081)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,14s,15r,16r)-9,14-dihydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O9 (622.4081)

(3s,4r,5r,6s)-4,5-dihydroxy-6-[(1-methoxy-5,7-dimethylnaphthalen-2-yl)oxy]oxan-3-yl (4as,4bs,7s,8as,10as)-7-ethyl-1,1,7-trimethyl-decahydro-2h-phenanthrene-4a-carboxylate

C38H54O7 (622.3869)